379 related articles for article (PubMed ID: 9657674)
1. Solution structure of the B-Myb DNA-binding domain: a possible role for conformational instability of the protein in DNA binding and control of gene expression.
McIntosh PB; Frenkiel TA; Wollborn U; McCormick JE; Klempnauer KH; Feeney J; Carr MD
Biochemistry; 1998 Jul; 37(27):9619-29. PubMed ID: 9657674
[TBL] [Abstract][Full Text] [Related]
2. NMR structure of the extended Myb cognate sequence and modeling studies on specific DNA-Myb complexes.
Radha PK; Patel PK; Hosur RV
Biochemistry; 1998 Jul; 37(28):9952-63. PubMed ID: 9665700
[TBL] [Abstract][Full Text] [Related]
3. Structure of the B-Myb DNA-binding domain in solution and evidence for multiple conformations in the region of repeat-2 involved in DNA binding: implications for sequence-specific DNA binding by Myb proteins.
Carr MD; Wollborn U; McIntosh PB; Frenkiel TA; McCormick JE; Bauer CJ; Klempnauer KH; Feeney J
Eur J Biochem; 1996 Feb; 235(3):721-35. PubMed ID: 8654422
[TBL] [Abstract][Full Text] [Related]
4. The NMR solution structure of a mutant of the Max b/HLH/LZ free of DNA: insights into the specific and reversible DNA binding mechanism of dimeric transcription factors.
Sauvé S; Tremblay L; Lavigne P
J Mol Biol; 2004 Sep; 342(3):813-32. PubMed ID: 15342239
[TBL] [Abstract][Full Text] [Related]
5. Myb-DNA recognition: role of tryptophan residues and structural changes of the minimal DNA binding domain of c-Myb.
Zargarian L; Le Tilly V; Jamin N; Chaffotte A; Gabrielsen OS; Toma F; Alpert B
Biochemistry; 1999 Feb; 38(6):1921-9. PubMed ID: 10026273
[TBL] [Abstract][Full Text] [Related]
6. Crystal structure of a ternary SAP-1/SRF/c-fos SRE DNA complex.
Mo Y; Ho W; Johnston K; Marmorstein R
J Mol Biol; 2001 Nov; 314(3):495-506. PubMed ID: 11846562
[TBL] [Abstract][Full Text] [Related]
7. NMR structure of the hRap1 Myb motif reveals a canonical three-helix bundle lacking the positive surface charge typical of Myb DNA-binding domains.
Hanaoka S; Nagadoi A; Yoshimura S; Aimoto S; Li B; de Lange T; Nishimura Y
J Mol Biol; 2001 Sep; 312(1):167-75. PubMed ID: 11545594
[TBL] [Abstract][Full Text] [Related]
8. Flexibility in the second half-site sequence recognised by the c-Myb R2 domain--in vitro and in vivo analysis.
Ording E; Bergholtz S; Brendeford EM; Jamin N; Gabrielsen OS
Oncogene; 1996 Sep; 13(5):1043-51. PubMed ID: 8806694
[TBL] [Abstract][Full Text] [Related]
9. The R2R3 Myb protein family in Entamoeba histolytica.
Meneses E; Cárdenas H; Zárate S; Brieba LG; Orozco E; López-Camarillo C; Azuara-Liceaga E
Gene; 2010 May; 455(1-2):32-42. PubMed ID: 20156532
[TBL] [Abstract][Full Text] [Related]
10. NMR structure of the DNA-binding domain of the cell cycle protein Mbp1 from Saccharomyces cerevisiae.
Nair M; McIntosh PB; Frenkiel TA; Kelly G; Taylor IA; Smerdon SJ; Lane AN
Biochemistry; 2003 Feb; 42(5):1266-73. PubMed ID: 12564929
[TBL] [Abstract][Full Text] [Related]
11. Solution structures of Myb DNA-binding domain and its complex with DNA.
Ogata K; Kanai H; Inoue T; Sekikawa A; Sasaki M; Nagadoi A; Sarai A; Ishii S; Nishimura Y
Nucleic Acids Symp Ser; 1993; (29):201-2. PubMed ID: 8247769
[TBL] [Abstract][Full Text] [Related]
12. Thermodynamics of specific and non-specific DNA binding by the c-Myb DNA-binding domain.
Oda M; Furukawa K; Ogata K; Sarai A; Nakamura H
J Mol Biol; 1998 Feb; 276(3):571-90. PubMed ID: 9551098
[TBL] [Abstract][Full Text] [Related]
13. 1H, 15N resonance assignment and three-dimensional structure of CYP1 (HAP1) DNA-binding domain.
Timmerman J; Vuidepot AL; Bontems F; Lallemand JY; Gervais M; Shechter E; Guiard B
J Mol Biol; 1996 Jun; 259(4):792-804. PubMed ID: 8683583
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of cyclin A/Cdk2 phosphorylation impairs B-Myb transactivation function without affecting interactions with DNA or the CBP coactivator.
Bessa M; Saville MK; Watson RJ
Oncogene; 2001 Jun; 20(26):3376-86. PubMed ID: 11423988
[TBL] [Abstract][Full Text] [Related]
15. Structural comparison of the PhoB and OmpR DNA-binding/transactivation domains and the arrangement of PhoB molecules on the phosphate box.
Okamura H; Hanaoka S; Nagadoi A; Makino K; Nishimura Y
J Mol Biol; 2000 Feb; 295(5):1225-36. PubMed ID: 10653699
[TBL] [Abstract][Full Text] [Related]
16. TATA-box dependent trans-activation of the human HSP70 promoter by Myb proteins.
Foos G; Natour S; Klempnauer KH
Oncogene; 1993 Jul; 8(7):1775-82. PubMed ID: 8510924
[TBL] [Abstract][Full Text] [Related]
17. Solution structure of the KIX domain of CBP bound to the transactivation domain of c-Myb.
Zor T; De Guzman RN; Dyson HJ; Wright PE
J Mol Biol; 2004 Mar; 337(3):521-34. PubMed ID: 15019774
[TBL] [Abstract][Full Text] [Related]
18. Structure, function, and dynamics of the dimerization and DNA-binding domain of oncogenic transcription factor v-Myc.
Fieber W; Schneider ML; Matt T; Kräutler B; Konrat R; Bister K
J Mol Biol; 2001 Apr; 307(5):1395-410. PubMed ID: 11292350
[TBL] [Abstract][Full Text] [Related]
19. Characterization and cell cycle-regulated expression of mouse B-myb.
Lam EW; Robinson C; Watson RJ
Oncogene; 1992 Sep; 7(9):1885-90. PubMed ID: 1501895
[TBL] [Abstract][Full Text] [Related]
20. Studies of c-myb gene regulation in MRL-lpr/lpr mice. Identification of a 5' c-myb nuclear protein binding site and high levels of binding factors in nuclear extracts of lpr/lpr lymph node cells.
Mountz JD; Steinberg AD
J Immunol; 1989 Jan; 142(1):328-35. PubMed ID: 2642505
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
